Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 6.54 percent. This is a 70.59 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $41.777 million which beat the analyst consensus estimate of $40.667 million by 2.73 percent. This is a 85.73 percent increase over sales of $22.493 million the same period last year.